Envirotainer, the global market leader in secure cold chain solutions for intercontinental shipments of pharmaceuticals, is launching the CryoSure® platform today. This -70oC solution, designed with today’s and tomorrow’s high demands in mind has unmatched performance, superior duration and is the most sustainable solution on the market.
The four models of the CryoSure® platform; X1, X2, X5 and X11.
Whereas most of the temperature-controlled pharmaceutical shipment solutions have historically involved temperature ranges of 2–8°C and 15–25°C, many pharma products and biospecimen samples require below -70°C shipments. More importantly, many new products within Cell & Gene Therapy, Clinical development, other non-finished products as well as mRNA vaccines have to be transported below -70°C.
Shipping products at below -70°C is very challenging. Long shipment durations combined with risks for delays, supply and handling of dry ice, and human errors are putting many shipments at risk. There is no room for failure when shipping life-saving products. This is the reason why Envirotainer now launches the revolutionary CryoSure® platform, based on the Linde Seccurus® technology and Envirotainer’s 35 years of experience. With its superior duration of up to 3 weeks, heat resistance and unparalleled ease of use, CryoSure® is the most reliable choice for -70°C cryogenic shipments, and for protecting patient safety.
With its unique feature set, CryoSure® sets a new standard for secure cryogenic solutions. For more information, please visit www.envirotainer.com/cryosure
“Envirotainer has been leading the way ever since the beginning of the temperature-controlled shipments and it is with great pride that we today announce the launch of CryoSure®. We believe CryoSure® fills a substantial gap in the cryogenic -70°C shipment market and significantly improves patient safety”, says Peter Gisel-Ekdahl, CEO at Envirotainer.
“This new CryoSure® technology takes pharma transportation to the next level by mitigating most if not all risks currently faced when shipping pharma products below -70°C. It is a game changer and is going to revolutionize this part of the market”, says Mattias Almgren, CryoSure® Platform Executive at Envirotainer.
“For many years, the strategy of Envirotainer has been to extend our offering through new innovative products and services and to expand into new segments. This technology fits perfectly into our circular business model and is going to be an important part of our offering going forward. The unique, premium quality, and completely reusable technology matches perfectly into Envirotainer’s global footprint”, says Fredrik Linnér, Chief Business Development Officer at Envirotainer.
